Neumann DR, Obuchowski NA, Difilippo FP: Preoperative 123I/99mTc-sestamibi subtraction SPECT and SPECT/CT in primary hyperparathyroidism. J Nucl Med, 2008. PubMed

Fugazzola L, Persani L, Vannucchi G, Carletto M, Mannavola D, Vigone MC, Cortinovis F, Beccaria L, Longari V, Weber G, Beck-Peccoz P: Thyroid scintigraphy and perchlorate test after recombinant human TSH: a new tool for the differential diagnosis of congenital hypothyroidism during infancy. Eur J Nucl Med Mol Imaging34(9):1498-503, 2007. PubMed

Schoen EJ, Clapp W, To TT, Fireman BH: The key role of newborn thyroid scintigraphy with isotopic iodide (123I) in defining and managing congenital hypothyroidism. Pediatrics 114(6):e683-8, 2004. PubMed

Hilditch TE, Dempsey MF, Bolster AA, McMenemin RM, Reed NS: Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I. Eur J Nucl Med Mol Imaging 29(6):783-8, 2002. PubMed

LaFranchi S: Congenital hypothyroidism: etiologies, diagnosis, and management. Thyroid 9(7):735-40, 1999. Review. PubMed

Morita S, Umezaki N, Ishibashi M, Kawamura S, Inada C, Hayabuchi N: Determining the breast-feeding interruption schedule after administration of 123I-iodide. Ann Nucl Med 12(5):303-6, 1998. PubMed